• 1  Reuther T, Bayrhammer J, Kerscher M. Effects of a three‐session skin rejuvenation treatment using stabilized hyaluronic acid‐based gel of non‐animal origin on skin elasticity: a pilot study. Arch Dermatol Res 2010;302(1):3745. Cross Ref link Pubmed link
  • 2  Ascher B, Bayerl C, Brun P, et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines – 6‐month interim results of a randomized, evaluator‐blinded, intra‐individual comparison study. J Cosmet Dermatol 2011;10:948. Cross Ref link Pubmed link
  • 3  Baumann LS, Shamban AT, Lupo MP, et al. JUVEDERM vs. ZYPLAST Nasolabial Fold Study Group. Comparison of smooth‐gel hyaluronic acid dermal fillers with cross‐linked bovine collagen: a multicenter, double‐masked, randomized, within‐subject study. Dermatol Surg 2007;33(Suppl. 2):S12835. Pubmed link
  • 4  Cohen SR, Holmes RE. Artecoll: a long‐lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 2004;114(4):96476; discussion 9779. Cross Ref link Pubmed link
  • 5  Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2‐year results from a pivotal single‐blind randomized controlled study. Dermatol Surg 2013; 39(11);160212. Cross Ref link Pubmed link
  • 6  Narins RS, Brandt F, Leyden J, et al. A randomized, double‐blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003;29(6):58895. Pubmed link
  • 7  Narins RS, Coleman W, Donofrio L, et al.. Nonanimal sourced hyaluronic acid‐based dermal filler using a cohesive polydensified matrix technology is superior to bovine collagen in the correction of moderate to severe nasolabial folds: results from a 6‐month, randomized, blinded, controlled, multicenter study. Dermatol Surg 2010;36;1:73040. Cross Ref link
  • 8  Narins RS, Brandt FS, Lorenc ZP, et al. A randomized, multi‐center study of the safety and efficacy of Dermicol‐P35 and non‐animal‐stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg 2007;33(Suppl. 2):S21321; discussion S21. Pubmed link
  • 9  Rzany B, Bayerl C, Bodokh I, et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6‐month interim results of a randomized, evaluator‐blinded, intra‐individual comparison study. J Cosmet Laser Ther 2011;13:10712. Cross Ref link Pubmed link
  • 10  Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human‐based collagen for the correction of nasolabial folds. Dermatol Surg 2007;33(Suppl. 2):S11221. Cross Ref link Pubmed link
  • 11  Fulton J, Caperton C, Weinkle S, Dewandre L. Filler injections with the blunt‐tip microcannula. J Drugs Dermatol 2012;11(9):1098103. Pubmed link
  • 12  Hexsel D, Soirefmann M, Porto MD, Siega C, Schilling‐Souza J, Brum C. Double‐blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg 2012;38(2):20714. Cross Ref link Pubmed link
  • 13  Sattler G. The tower technique and vertical supraperiosteal depot technique: novel vertical injection techniques for volume‐efficient subcutaneous tissue support and volumetric augmentation. J Drugs Dermatol 2012;11(8):S457. Pubmed link
  • 14  Moyle GJ, Baldwin C, Langroudi B, et al. A randomized open‐label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004;5(2):827. Cross Ref link Pubmed link
  • 15  Perry CM. Poly‐L‐lactic acid. Am J Clin Dermatol 2004;5(5):3616; discussion 367–8. Cross Ref link Pubmed link
  • 16  Valantin MA, Aubron‐Olivier C, Ghosn J, et al. Polylactic acid implants (New‐Fill) to correct facial lipoatrophy in HIV‐infected patients: results of the open‐label study VEGA. Aids 2003;17(17):24717. Cross Ref link Pubmed link
  • 17  Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly‐l‐lactic acid versus human‐based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol 2010;62(3):44862. Cross Ref link Pubmed link
  • 18  Brandt FS, Cazzaniga A, Baumann L, et al. Investigator global evaluations of efficacy of injectable poly‐L‐lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Aesthet Surg J 2011;31(5):5218. Cross Ref link Pubmed link
  • 19  Roßner F, Roßner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: eight year results from the Injectable Filler Safety‐Study (IFS‐Study). J Cosmet Dermatol 2009;8(1):1418. Cross Ref link Pubmed link
  • 20  Schierle CF, Casas LA. Nonsurgical rejuvenation of the aging face with injectable poly‐L‐lactic acid for restoration of soft tissue volume. Aesthet Surg J 2011;31(1):95109. Cross Ref link Pubmed link
  • 21  Avery C, Clifford N. Foreign body granulomatous reaction of the temporal region following dermal filler administration. Br J Oral Maxillofac Surg 2010;48(6):488. Cross Ref link Pubmed link
  • 22  Goldan O, Garbov‐Nardini G, Regev E, Orenstein A, Winkler E. Late‐onset infections and granuloma formation after facial polylactic acid (New‐Fill) injections in women who are heavy smokers. Plast Reconstr Surg 2008;121(5):336e338e. Cross Ref link Pubmed link
  • 23  Sperling B, Bachmann F, Hartmann V, Erdmann R, Wiest L, Rzany B. The current state of treatment of adverse reactions to injectable fillers. Dermatol Surg 2010;36(Suppl. 3):1895904. Cross Ref link Pubmed link
  • 24  Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator‐blind, multicentre comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg 2005;115(1):2829. Pubmed link
  • 25  Rzany B, Bayer l C, Bodokh I, et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6‐month interim results of a randomized, evaluator‐blinded, intra‐individual comparison study. J Cosmet Laser Ther 2011;13:10712. Cross Ref link Pubmed link
  • 26  Rzany B, Cartier H, Kestemont P, et al. Full‐face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months. Dermatol Surg 2012;38(7 Pt 2):115361. Cross Ref link Pubmed link
  • 27  Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC 3rd. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg 2008;121(1):28997. Cross Ref link Pubmed link
  • 28  Pinsky MA, Thomas JA, Murphy DK, Walker PS. Juvéderm vs. Zyplast Nasolabial Fold Study Group. Juvéderm injectable gel: a multicenter, double‐blind, randomized study of safety and effectiveness. Aesthet Surg J 2008;28(1):1723. Cross Ref link Pubmed link
  • 29  Callan P, Goodman GJ, Carlisle I, et al. Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 2013;6:819. Cross Ref link Pubmed link
  • 30  Eccleston D, Murphy DK. Juvéderm(®) Volbella in the perioral area: a 12‐month prospective, multicenter, open‐label study. Clin Cosmet Investig Dermatol 2012;5:16772. Pubmed link
  • 31  Nast A, Reytan N, Hartmann V, et al. Efficacy and durability of two hyaluronic acid‐based fillers in the correction of nasolabial folds: results of a prospective, randomized, double‐blind, actively controlled clinical pilot study. Dermatol Surg 2011;37:76875. Pubmed link
  • 32  Rzany B, Becker‐Wegerich P, Bachmann F, Erdmann R, Wollina U. Hyaluronidase in the correction of hyaluronic acid‐based fillers: a review and a recommendation for use. J Cosmet Dermatol 2009;8(4):31723. Cross Ref link Pubmed link
  • 33  Cavevellini M, Gazzola R, Metalla M, et al. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers Aesth Surg J 2013;33(8):116774. Cross Ref link
  • 34  Comite SL, Liu JF, Balasubramanian S, et al. Treatment of HIV‐associated facial lipoatrophy with Radiance FN (Radiesse). Dermatol Online J 2004;10(2):2. Pubmed link
  • 35  Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open‐label, 18‐month trial of calcium hydroxylapatite (Radiesse) for facial soft‐tissue augmentation in patients with human immunodeficiency virus‐associated lipoatrophy: one‐year durability. Plast Reconstr Surg 2006;118(Suppl. 3):S3445. Cross Ref link
  • 36  Moers‐Carpi MM, Vogt S, Santos BM, et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 2007;33(Suppl. 2):S14451. Pubmed link
  • 37  Moers‐Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12‐month, multicenter, prospective, randomized, controlled, split‐face trial. Dermatol Surg 2008;34(2):21015. Cross Ref link Pubmed link
  • 38  Feeney JN, Fox JJ, Akhurst T. Radiological impact of the use of calcium hydroxylapatite dermal fillers. Clin Radiol 2009;64(9):897902. Cross Ref link Pubmed link
  • 39  Sklar JA, White SM. Radiance FN: a new soft tissue filler. Dermatol Surg 2004;30(5):7648; discussion 768. Pubmed link
  • 40  Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 2004;6(4):2349. Cross Ref link Pubmed link
  • 41  Kim DW, Yoon ES, Ji YH, Park SH, Lee BI, Dhong ES. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aesthet Surg 2011;64(12):15905. Cross Ref link Pubmed link
  • 42  Sung MS, Kim HG, Woo KI, Kim YD. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler. Ophthal Plast Reconstr Surg 2010;26(4):28991. Cross Ref link Pubmed link
  • 43  Schuller‐Petrović S, Pavlović MD, Schuller SS, Schuller‐Lukić B, Neuhold N. Early granulomatous foreign body reactions to a novel alginate dermal filler: the system's failure? J Eur Acad Dermatol Venereol 2013;27(1):1213. Cross Ref link Pubmed link
  • 44  Homicz MR, Watson D. Review of injectable materials for soft tissue augmentation. Facial Plast Surg 2004;20(1):219. Cross Ref link Pubmed link
  • 45  Cooperman LS, Mackinnon V, Bechler G, et al. Injectable collagen: a six‐year clinical investigation. Aesthetic Plast Surg 1985;9(2):14551. Cross Ref link Pubmed link
  • 46  Matti BA, Nicolle FV. Clinical use of Zyplast in correction of age‐ and disease‐related contour deficiencies of the face. Aesthetic Plast Surg 1990;14(3):22734. Cross Ref link Pubmed link
  • 47  Monstrey SJ, Pitaru S, Hamdi M, et al. A two‐stage phase I trial of Evolence30 collagen for soft‐tissue contour correction. Plast Reconstr Surg 2007;120:30311. Cross Ref link Pubmed link
  • 48  Narins RS, Brandt FS, Lorenc ZP, Maas CS, Monheit GD, Smith SR. Twelve‐month persistency of a novel ribose‐cross‐linked collagen dermal filler. Dermatol Surg 2008;34(Suppl. 1):S319. Pubmed link
  • 49  Shoshani D, Markovitz E, Cohen Y, Heremans A, Goldlust A. Skin test hypersensitivity study of a cross‐linked, porcine collagen implant for aesthetic surgery. Dermatol Surg 2007;33(Suppl. 2):S1528. Pubmed link
  • 50  Braun M, Braun S. Nodule formation following lip augmentation using porcine collagen‐derived filler. J Drugs Dermatol 2008;7(6):57981. Pubmed link
  • 51  Baumann L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg 2004;20(2):1258. Cross Ref link Pubmed link
  • 52  Orentreich DS. Liquid injectable silicone: techniques for soft tissue augmentation. Clin Plast Surg 2000;27(4):595612. Pubmed link
  • 53  Webster RC, Fuleihan NS, Gaunt JM, et al. Injectable silicone for facial soft‐tissue augmentation. Arch Otolaryngol Head Neck Surg 1986;112(3):2906. Cross Ref link Pubmed link
  • 54  Ersek RA, Gregory SR, Salisbury AV. Bioplastique at 6 years: clinical outcome studies. Plast Reconstr Surg 1997;100(6):15704. Cross Ref link Pubmed link
  • 55  Ficarra G, Mosqueda‐Taylor A, Carlos R. Silicone granuloma of the facial tissues: a report of seven cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94(1):6573. Cross Ref link Pubmed link
  • 56  Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration. Aesthetic Plast Surg 1996;20(3):26776. Cross Ref link Pubmed link
  • 57  Requena C, Izquierdo MJ, Navarro M, et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 2001;23(3):197202. Cross Ref link Pubmed link
  • 58  Hevia O. Six‐year experience using 1,000‐centistoke silicone oil in 916 patients for soft‐tissue augmentation in a private practice setting. Dermatol Surg 2009;35(Suppl. 2):164652. Cross Ref link Pubmed link
  • 59  Fulton J, Caperton C. The optimal filler: immediate and long‐term results with emulsified silicone (1,000 centistokes) with cross‐linked hyaluronic acid. J Drugs Dermatol 2012;11(11):133641. Pubmed link
  • 60  Breiting V, Aasted A, Jorgensen A, Opitz P, Rosetzsky A. A study on patients treated with polyacrylamide hydrogel injection for facial corrections. Aesthetic Plast Surg 2004;28(1):4553. Cross Ref link Pubmed link
  • 61  De Cassia Novaes W, Berg A. Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study. Aesthetic Plast Surg 2003;27(5):37680. Cross Ref link Pubmed link
  • 62  Narins RS, Coleman WP 3rd, Rohrich R, et al. 12‐month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft‐tissue filler. Dermatol Surg 2010;36(Suppl. 3):181929. Cross Ref link Pubmed link
  • 63  Wang YB, Huang JJ, Qiao Q, et al. [Clinically analyzing the possible side‐effects after injecting hydrophilic poly‐acrylamide gel as a soft‐tissue filler.] Zhonghua Zheng Xing Wai Ke Za Zhi 2003;19(5):32830. Pubmed link
  • 64  Bjarnsholt T, Tolker‐Nielsen T, Givskov M, Janssen M, Christensen LH. Detection of bacteria by fluorescence in situ hybridization in culture‐negative soft tissue filler lesions. Dermatol Surg 2009;35(Suppl. 2):16204. Cross Ref link Pubmed link
  • 65  Alijotas‐Reig J, Fernández‐Figueras MT, Puig L. Late‐onset inflammatory adverse reactions related to soft tissue filler injections. Clin Rev Allergy Immunol 2013;45(1):97108. Cross Ref link Pubmed link
  • 66  Protopapa C, Sito G, Caporale D, Cammarota N. Bio‐Alcamid in drug‐induced lipodystrophy. J Cosmet Laser Ther 2003;5(3–4):22630. Cross Ref link Pubmed link
  • 67  Schelke LW, van den Elzen HJ, Canninga M, Neumann MH. Complications after treatment with polyalkylimide. Dermatol Surg 2009;35(Suppl. 2):16258. Cross Ref link Pubmed link
  • 68  George DA, Erel E, Waters R. Patient satisfaction following Bio‐Alcamid injection for facial contour defects. J Plast Reconstr Aesthet Surg 2012;65(12):16226. Cross Ref link Pubmed link
  • 69  Nadarajah JT, Collins M, Raboud J, Su D, Rao K, Loutfy MR, Walmsley S. Infectious complications of Bio‐Alcamid filler used for HIV‐related facial lipoatrophy. Clin Infect Dis 2012;55(11):156874. Cross Ref link Pubmed link
  • 70  Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10‐year history, indications, techniques, and complications. Dermatol Surg 2003;29(6):57387; discussion 587. Pubmed link
  • 71  Cohen SR, Berner CF, Busso M, et al.. ArteFill: a long‐lasting injectable wrinkle filler material – summary of the US Food and Drug Administration trials and a progress report on 4‐ to 5‐year outcomes. Plast Reconstr Surg 2006;118(Suppl. 3):S6476. Cross Ref link
  • 72  Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg 2008;34(3):32635; discussion 335. Pubmed link
  • 73  Bergeret‐Galley C, Latouche X, Illouz YG. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg 2001;25(4):24955. Cross Ref link Pubmed link
  • 74  Roßner M, Roßner F, Bachmann F, Wiest L, Rzany B. Increased risk of severe adverse reactions to‐wards an injectable filler composed of a fixed combination of methacrylate particles and hyaluronic acid (Dermalive). Derm Surgery 2009;35(Suppl. 1):36774. Cross Ref link
  • 75  Waris E. Alloplastic injectable biomaterials for soft tissue augmentation: a report on two cases with complications associated with a new material (DermaLive) and a review of the literature. Eur J Plast Surg 2003;26:3505. Cross Ref link
  • 76  Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft‐tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg 2013;132(4 Suppl. 2):S521. Cross Ref link
  • 77  Raoof N, Salvi SM. Self injection of dermal filler: an under‐diagnosed entity? Br J Dermatol 2015;172(3):7823. Cross Ref link Pubmed link
  • 78  Friedman PM, Mafong EA, Kauvar ANB, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002;28(6):4914. Pubmed link
  • 79  Skipr editorial. Tot nu toe 25 klachten over rimpelfiller [Up to now, 25 complaints about a wrinkle filler]. http://www.skipr.nl/actueel/id12523‐tot‐nu‐toe‐25‐klachten‐over‐rimpelfiller.html (last accessed March 2015).
  • 80  Dadzie OE, Mahalingam M, Parada M, et al. Adverse cutaneous reactions to soft tissue fillers‐a review of the histological features. J Cutan Pathol 2008;35:53648. Cross Ref link Pubmed link
  • 81  Carruthers JD1, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg 2014;134(6):1197201. Cross Ref link Pubmed link
  • 82  Lazzeri D, Agostini T, Figus M, et al. Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012;129(4):9951012. Cross Ref link Pubmed link
  • 83  Kim YJ, Choi KS. Bilateral blindness after filler injection. Plast Reconstr Surg 2013;131(2):298e9e. Cross Ref link Pubmed link
  • 84  Park SW, Woo SJ, Park KH, et al. Latrogenic retinal artery occlusion caused by cosmetic facial filler injections. Am J Ophthalmol 2012;154(4):65362.e1. Cross Ref link Pubmed link
  • 85  Marmur ES, Taylor SC, Grimes PE, Boyd CM, Porter JP, Yoo JY. Six‐month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI. Dermatol Surg 2009;35(Suppl. 2):16415. Cross Ref link Pubmed link
  • 86  Downie JB, Grimes PE, Callender VD. A multicenter study of the safety and effectiveness of hyaluronic acid with a cohesive polydensified matrix for treatment of nasolabial folds in subjects with Fitzpatrick skin types IV, V, and VI. Plast Reconstr Surg 2013;132(4 Suppl. 2):S417. Cross Ref link
  • 87  Grimes PE, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol 2009;8(3):1628. Cross Ref link Pubmed link
  • 88  Arsiwala SZ. Safety and persistence of non‐animal stabilized hyaluronic acid fillers for nasolabial folds correction in 30 Indian patients. J Cutan Aesthet Surg 2010;3(3):15661. Cross Ref link Pubmed link
  • 89  De Maio M, Rzany B. Injectable Fillers in Aesthetic Medicine. Heidelberg: Springer, 2006. Cross Ref link
  • 90  Cassuto D, Marangoni O, De Santis G, et al. Advanced laser techniques for filler‐induced complications. Dermatol Surg 2009;35(2):168995. Cross Ref link Pubmed link
  • 91  Hwang CJ, Morgan PV, Pimentel A, Sayre JW, Goldberg RA, Duckwiler G. Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model. Ophthal Plast Reconstr Surg 2015, Mar 18 (epub ahead of print).